Ophthalmic Case Studies and Novel Approach

In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.

 

    Related Conference of Ophthalmic Case Studies and Novel Approach

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in